A. B. Deisseroth

Medicine · Health Sciences

32h-index3.8kcitations103works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(16), Virus-based gene therapy research(16), Chronic Myeloid Leukemia Treatments(16), Cancer-related Molecular Pathways(10), Immunotherapy and Immune Responses(9)

Publications102 total

Title Page / Contents / Preface
2015
Subject Index
2015
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases
Cancer Gene Therapy·2012· 11 cited
Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells
Gene Therapy·2010· 11 citedOpen Access
Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors
Bone Marrow Transplantation·2009· 1 cited
Results of retroviral and adenoviral approaches to cancer gene therapy
Stem Cells·2009· 20 citedOpen Access
Targeting of chemotherapy to Tie-2-receptor positive angiogenic endothelial cells of tumor vasculature.
Cancer Research·2009
Donor lymphocyte infusions from Ad-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost (VPP) vaccinated allodonors decrease tumor cell growth post allograft
Journal of Clinical Oncology·2007
44: Pre-clinical study of the effect of the As-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost vaccine in elderly recipients for suppression of recurrent cancer following allografting and donor lymphocyte infusions (DLI)
Biology of Blood and Marrow Transplantation·2007Open Access
Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells
Cancer Gene Therapy·2007· 32 cited
International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China
Cancer Gene Therapy·2006· 4 cited
Vaccine for prevention of breast cancer
Journal of Clinical Oncology·2006
Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy
Cancer Gene Therapy·2006· 33 cited
Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes
Gene Therapy·2006· 8 cited
Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy
Cancer Gene Therapy·2005· 21 cited
Vector vaccine overcomes anergy
Journal of Clinical Oncology·2004
Vector vaccine overcomes anergy
Journal of Clinical Oncology·2004
Tumor specific targeting of adenoviral vectors to cancer
International Journal of Hematology·2002
Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit.
PubMed·2001· 2 cited
The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
PubMed·2001· 65 cited
page 1 of 6Next →

Frequent Co-authors

Donna Przepiorka(7), Cindy Ippoliti(6), Sergio Giralt(6), Börje S. Andersson(6), Moshe Talpaz(5), Rakesh Mehra(5), David F. Claxton(4), Hagop M. Kantarjian(4), Issa F. Khouri(4), Richard E. Champlin(4), Koen van Besien(4), M Körbling(4), Elie G. Hanania(4), Siqing Fu(4), J. P. Hester(3), CF LeMaistre(3), C Meneghetti(3), Michael G. Rosenblum(3), James M. Reuben(3), K Parker(3)